🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

57 notícias encontradas para "treatments"
Chromatin hubs help decide whether T cells fight chronic threats or fail
Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks. But a new pair of papers by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) points to a way to understand how this exhaust
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i
Cancer evolution study reveals biology of glioma progression
Cancer evolution study reveals biology of glioma progression
A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma cells to transform into immature, stem cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Center,
Foto: Veronica / Pexels
Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure
Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps the rise in artemisinin resistance in the region and sug
Scientists improve the analgesic efficacy of morphine
Scientists improve the analgesic efficacy of morphine
Scientists at the Department of Cell Biology of the University of Malaga have taken a step forward in the search for more effective treatments for pain with a new study that advances efforts to mitigate the addictive effects of morphine—one of the main drugs used for this purpose
Researchers develop a safer, more reliable material for growing small-scale models of the
Researchers develop a safer, more reliable material for growing small-scale models of the
Scientists can use patient-derived tissue samples to grow miniature versions of human organs, allowing them to test new medications and disease treatments for personalized care.
Enhancing safety of advanced radiotherapy cancer treatments for children
Researchers from the National Physical Laboratory (NPL), Heidelberg University Hospital and the German Cancer Research Center (DKFZ) have published new findings that improve understanding of secondary neutron exposure during pediatric ion beam therapy, an important area of study
Can cosmetic procedures become addictive? Study links addiction risk to social media and b
As cosmetic procedures surge worldwide and beauty content increasingly dominates social media platforms, a new study from the Hebrew University of Jerusalem suggests that for some women, cosmetic treatments may begin to resemble compulsive or addiction-like behavior. The study, l
Why the fastest-growing Ebola outbreak in history is becoming more challenging
The Ebola outbreak in eastern Congo is now the fastest-growing one in history, and new challenges keep emerging even as work begins on a study of two badly needed treatments for a type of Ebola that currently has none.
A natural compound steps into the estrogen arena
Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age. Existing treatments—hormonal drugs and selective estrogen receptor modulators—have side effects and cannot reliably prevent recurrence. This is w
An experimental Alzheimer's drug shows promise targeting a different brain protein, new st
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.